You searched for "stroke"

4925 results found

Haag-Streit Academy announces course schedule for 2025

Haag-Streit Academy are pleased to announce their course schedule for 2025, which features eight slit lamp and biometry courses in prime locations across the UK. The courses offer attendees the vital skills and knowledge to utilise their slit lamp and...

HASA OPTIX Certifies as a B Corporation

Premium recyclable ophthalmic instrument company HASA OPTIX announces its certification as a B Corporation (B Corp) company. In a press release, the Brussels-based scale-up confirmed its score of 109.7 points on the B Impact Assessment, in which nonprofit B Lab...

Glaukos Launches iStent infinite® in the UK Following MDR Approval

Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...

My Top Five: Influential ophthalmologists

Ophthalmology has witnessed remarkable evolution and advancements throughout history. The field has undergone dramatic change and development since the times of Ancient Egypt where the first reference to eyes was made in the Code of Hammurabi (2250 BC) [1]. From...

The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...

Conference Preview: UKEGS 2025

We’re always ecstatic when one of our media partners bring their conference to Scotland, especially when they land in our hometown of Edinburgh. Taking place in The Assembly Rooms, a beautiful 18th century venue in the heart of Edinburgh’s New...

Ambient scribes: The silent revolution

Clinical practice is in the midst of a profound digital transformation with a new wave of technology gaining increasing prominence: ambient scribes. These AI-powered tools streamline documentation by converting doctor–patient conversations into structured clinical notes in near real time. Healthcare...

BBC News Highlights New Approach to Treating Ocular Hypotony

Ocular hypotony has been in the spotlight following recent BBC News coverage highlighting how new clinical research is delivering meaningful benefits for patients affected by this sight threatening condition. The feature draws attention to a newly published study from the...

Through the bubble: A patient’s perspective on macula hole surgery pre- and postoperatively

The evolution of ophthalmic surgical practice over the past seven decades has been extraordinary. Within this period, the first vitrectomy was performed, establishing a foundation for what is now an operation performed thousands of times per year in the UK...

Scottish budget 2026–27: Optometry Scotland welcomes continued investment in community eyecare

Optometry Scotland (OS) welcomes the Scottish Budget 2026–27, which confirms continued investment in community optometry and reinforces its established role in delivering accessible eyecare across Scotland. The Budget confirms community eyecare funding of £144.5 million for 2026–27, representing a cash...

Everyday diabetes medicine could treat common cause of blindness

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

At least 70 percent of cataract patients could benefit from toric IOL

More than two-thirds of cataract patients could benefit from toric intraocular lenses (IOL), according to findings presented at 100% Optical. Consultant ophthalmologist Nigel Kirkpatrick set out how astigmatism is a significant issue for cataract surgery patients during a main stage...